Overview

Multiple Dose BE Study With Nevirapine 400mg PR Tablets

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The objective of this steady state pivotal study is to compare the rate and extent of absorption and to evaluate Bioequivalence of test drug compared to the approved reference product in HIV infected individuals
Phase:
Phase 1
Details
Lead Sponsor:
Ratiopharm GmbH
Treatments:
Nevirapine